Bone Care, GenTel, MyWeather

The sale of Bone Care International for $600 million to Massachusetts based Genzyme Corporation is underway as their operations are immediately being integrated into Genzymes Renal Business unit. Meanwhile GenTel BioSurfaces will receive a $250,000 loan from the Department of Commerce Technology Venture Fund Program...

One of Wisconsin's most prominent pharmaceutical companies has been purchased, its stock delisted and its name changed. The move will result in a continued, but perhaps limited, presence in Wisconsin, create potential opportunites for the state's life science industry, increase distribution of their drug and...

Researchers at the Ludwig Institute for Cancer Research, using technology made by Madison-based NimbleGen Systems, have developed a method to identify thousands of regulatory sequences in the human genome....

Madison, Wis. - The June 20 issue of The Scientist, named Madison, "the Midwest's low-key hotspot" for biotechnology. The publication reported that the city's research facilities and open community make it one of the best climates for starting or continuing a biotech and life sciences...